140 results on '"Duvoux, Christophe"'
Search Results
2. THU-494 Selective internal radiation therapy for unresectable hepatocellular carcinoma in a tertiary center in France, update and final analysis
3. SAT-010 Elaboration of a one-year mortality score for first elective liver transplantation recipients over 60 years based on the results of the french national cohort between 2007 and 2017
4. SAT-020 Evaluation of 18FDG-PET/CT for prediction of waitlist dropout and post transplantation recurrence in patients listed for hepatocellular carcinoma
5. FRI-171 Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
6. GS-010 Early liver transplantation for severe alcohol-related hepatitis: long-term data of the french-belgian controlled study (QuickTrans)
7. SAT-048 Long-term mortality and risk factors associated with mortality after liver transplantation in the modern era
8. LBP-026 The global prospective observational study to evaluate the role of ‘liver transplantation in patients with cirrhosis and severe acuteon-chronic liver failure (CHANCE)’: study design, demographics and overall outcome
9. LBO-004 Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
10. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)
11. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation
12. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: The SURFASA score
13. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study
14. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry
15. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma
16. ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients
17. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
18. Evaluation of a delayed liver transplant strategy for patients listed for hepatocellular carcinoma treated with resection or thermo-ablation as a bridge to liver transplantation; the DELTAS-HCC study
19. Long-term outcome following liver transplantation for chronic liver disease in intensive care unit: the French nationwide experience
20. Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER clinical trial
21. Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence – The ANRS CUPILT study
22. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
23. Liver resection for hepatocellular carcinoma in 313 Western patients: Tumor biology and underlying liver rather than tumor size drive prognosis
24. Long term results of liver transplantation for Wilson’s disease: Experience in France
25. Acute-on-chronic liver failure due to severe intrahepatic vaso-occlusion and recurrence of the intial disease: 2 major features in liver transplantation for severe sickle-cell-related hepatopathy
26. Predictive factors of tumor recurrence after liver transplantation for hepatocellular carcinoma: analysis of a multicenter prospective study including 371 patients
27. Recurrence of primary sclerosing cholangitis after liver transplantation: a french cohort study including 571 patients
28. Transarterial radioembolisation in non resectable hepatocellular carcinoma in curative strategies: a single centre experience
29. Liver involvement in systemic light chain amyloidosis: is the heart guilty?
30. Liver transplantation for hepatocellular carcinoma with extended criteria: performance and applicability of the AFP score after official adoption by the French Organ Sharing Organization ABM: 5-year outcomes
31. Treatment of recurrent HCV infection following liver transplantation: Results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin
32. AS010 - Reassessment of the risk of recurrence (R3) after liver transplantation for HCC: validation of the R3 v.2 score and comparison with existing models: results of a multinational analysis in 2,444 patients
33. THU-511 - Long-term outcome following liver transplantation for chronic liver disease in intensive care unit: the French nationwide experience
34. THU-498 - Evaluation of a delayed liver transplant strategy for patients listed for hepatocellular carcinoma treated with resection or thermo-ablation as a bridge to liver transplantation; the DELTAS-HCC study
35. LBP-07 - Validation of the R3-AFP model for risk prediction of HCC recurrence after liver transplantation in the SiLVER clinical trial
36. Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference
37. Long-term patient and graft survival after liver transplantation for autoimmune hepatitis
38. Early liver transplantation for severe alcoholic hepatitis not responding to medical treatment: results of the French-Belgian prospective study QuickTrans
39. International, multicenter study on the outcome of locoregional therapy before liver transplant for hepatocellular carcinoma extending the Milan criteria
40. Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study
41. Reassessment of the risk of recurrence (R3) after liver transplantation for HCC: validation of the R3 v.2 score and comparison with existing models: results of a multinational analysis in 2,444 patients
42. SAT312 - Predictive factors of tumor recurrence after liver transplantation for hepatocellular carcinoma: analysis of a multicenter prospective study including 371 patients
43. SAT269 - Acute-on-chronic liver failure due to severe intrahepatic vaso-occlusion and recurrence of the intial disease: 2 major features in liver transplantation for severe sickle-cell-related hepatopathy
44. SAT252 - Liver transplantation for hepatocellular carcinoma with extended criteria: performance and applicability of the AFP score after official adoption by the French Organ Sharing Organization ABM: 5-year outcomes
45. SAT239 - Recurrence of primary sclerosing cholangitis after liver transplantation: a french cohort study including 571 patients
46. FRI281 - Liver involvement in systemic light chain amyloidosis: is the heart guilty?
47. THU573 - Transarterial radioembolisation in non resectable hepatocellular carcinoma in curative strategies: a single centre experience
48. De novo tumours after liver transplantation in adults. What is the actual risk?
49. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions
50. Low HCV replication levels in end-stage hepatitis C virus-related liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.